Latest news

Time to raise the beer game: Chr. Hansen unveils two strains for more flavors in non-alcoholic brewing with SmartBev® NEER®

Time to raise the beer game: Chr. Hansen unveils two strains for more flavors in non-alcoholic brewing with SmartBev® NEER®

November 14, 2023 – In line with the growing demand for non-alcoholic beer options and flavor variety, Chr. Hansen is committed to providing brewers with top-notch technology to cater to this lucrative market segment and launches two new strains for non-alcoholic brewing.
"With new strains in our portfolio, brewers can now offer an even greater variety of flavors to consumers who are seeking no
Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain

Canada approves gut-brain axis health claims for Chr. Hansen probiotic strain

Health Canada authorizes functional claims that the probiotic strain DDS-1® “helps alleviate perceived stress and improve irritable bowel syndrome-related quality of life in adolescents and adults”

The ‘gut-brain axis’ has become one of the most cutting-edge areas of research over the past few years, diving into how the fascinating interplay between the brain, gut and microbiome can impact

Chr. Hansen reports strong Q4 performance despite a challenging environment

Chr. Hansen reports strong Q4 performance despite a challenging environment

Statement by CEO Mauricio Graber: “Supported by a strong Q4 performance, Chr. Hansen delivered a solid result for the first twelve months of the extended financial year 2022/23 at the upper end of our guidance with 11% organic revenue growth and an EBIT margin b.s.i. of 26.9%. Throughout the year, we have demonstrated the attractiveness of the markets we serve and the resilience of our business mo

Chr. Hansen achieves first step Chinese approvals of 3 HMOs

Chr. Hansen achieves first step Chinese approvals of 3 HMOs

The three HMOs, 2’-FL, LNT and 3-FL, have just been approved by the Chinese Ministry of Agriculture and Rural Affairs, MARA, bringing Chr. Hansen’s HMOs one step closer to final approval for the Chinese market.

New Chr. Hansen review of 26 clinical studies reports beneficial effects of HMO in gut health and immune system

New Chr. Hansen review of 26 clinical studies reports beneficial effects of HMO in gut health and immune system

Clinical studies in infants, children and adults consistently found that HMO supplementation was safe and well tolerated.

Chr. Hansen reports solid results for Q3 with 9% organic growth

Chr. Hansen reports solid results for Q3 with 9% organic growth

Strong execution by the organization drives solid Q3 results
Statement by CEO Mauricio Graber: “The solid results for Q3 prove the strength of the Chr. Hansen organization which continues to deliver first-class products and innovative solutions to customers around the world, while the process with Novozymes to complete the proposed merger is progressing. Organic growth came in at 9%, driven ma

Change of Management in Bacthera AG

Change of Management in Bacthera AG

CEO Lukas Schüpbach has decided to step down from his role at Bacthera, effective August 31st, 2023
Lukas Schüpbach has been with the company since 2020. Lukas has played a critical role in the establishment of Bacthera as a leading global end-to-end contract development and manufacturing service provider in the Live Biotherapeutics industry with clinical and commercial manufacturing sites in S

Social media

Сега е времето за биорешенија

Сега е времето за биорешенија

Chr. Hansen
Vreme je za biorešenja

Vreme je za biorešenja

Chr. Hansen
Час для біологічних рішень настав

Час для біологічних рішень настав

Chr. Hansen
Korisnički i aplikativni centar u Polhajmu

Korisnički i aplikativni centar u Polhajmu

Chr. Hansen
Център за клиенти и приложения в Pohlheim

Център за клиенти и приложения в Pohlheim

Chr. Hansen
Сега е времето за биорешения

Сега е времето за биорешения

Chr. Hansen
Nastal čas pro biologická řešení

Nastal čas pro biologická řešení

Chr. Hansen
Teraz je čas na biologické riešenia

Teraz je čas na biologické riešenia

Chr. Hansen
Culturas congeladas Chr. Hansen – instruções para recebimento

Culturas congeladas Chr. Hansen – instruções para recebimento

Chr. Hansen
科汉森深冷型菌种 – 货物接收指南

科汉森深冷型菌种 – 货物接收指南

Chr. Hansen
We're finally ready to move in! Today, we've opened the doors to Chr. Hansen's new Innovation Campus in Hoersholm, Denmark. Here's a sneak peek into the beautiful buildings, which will make home to all Hansenites working at site Hoersholm and be a hub for science, innovation and the biosolutions of the future. A big thank you to everyone who has been involved in the project. #Science #Innovation #Campus #Building

We're finally ready to move in! Today, we've opened the doors to Chr. Hansen's new Innovation Campus in Hoersholm, Denmark. Here's a sneak peek into the beautiful buildings, which will make home to all Hansenites working at site Hoersholm and be a hub for science, innovation and the biosolutions of the future. A big thank you to everyone who has been involved in the project. #Science #Innovation #Campus #Building

chr.hansen
Are you up for a science challenge? Back in Spring, our culture collection reached 50,000 deposits, making it one of the largest commercial culture collections in the world🧫 We have found four images of our most known ones. Can you pair the images with the below names? 🤔 A. Bacillus Subtilis B. Bifidobacterium (BB12 ®) C. Lactobacillus Rhamnosus (LGG ®) D. Streptococcus thermophilus For example, an answer could be A4. We will reveal the correct answer on Tuesday next week.

Are you up for a science challenge? Back in Spring, our culture collection reached 50,000 deposits, making it one of the largest commercial culture collections in the world🧫 We have found four images of our most known ones. Can you pair the images with the below names? 🤔 A. Bacillus Subtilis B. Bifidobacterium (BB12 ®) C. Lactobacillus Rhamnosus (LGG ®) D. Streptococcus thermophilus For example, an answer could be A4. We will reveal the correct answer on Tuesday next week.

chr.hansen

Contacts

Helle Rexen

Helle Rexen

Press contact Media relations officer +45 20 74 28 40
Kathrine Westermann

Kathrine Westermann

Press contact Head of Media Relations +45 23 81 55 95

About us

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 150 years to enable sustainable agriculture, better food and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 50,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As one of the world’s most sustainable companies, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose – To grow a better world. Naturally. – is at the heart of everything we do.

Chr. Hansen Holding A/S
Boege Allé 10-12
DK-2970 Hoersholm
Denmark
Chr. Hansen website
Investor Relations
Read more about Chr. Hansen